Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Return on Assets (2016 - 2020)

Larimar Therapeutics (LRMR) has disclosed Return on Assets for 6 consecutive years, with 0.36% as the latest value for Q3 2019.

  • For the quarter ending Q3 2019, Return on Assets rose 20.0% year-over-year to 0.36%, compared with a TTM value of 0.36% through Sep 2019, up 20.0%, and an annual FY2018 reading of 0.54%, down 10.0% over the prior year.
  • Return on Assets was 0.36% for Q3 2019 at Larimar Therapeutics, down from 0.35% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.25% in Q2 2015 and bottomed at 0.66% in Q2 2018.
  • Average Return on Assets over 5 years is 0.44%, with a median of 0.45% recorded in 2017.
  • The sharpest move saw Return on Assets dropped -22bps in 2016, then soared 31bps in 2019.
  • Year by year, Return on Assets stood at 0.37% in 2015, then decreased by -13bps to 0.42% in 2016, then fell by -23bps to 0.52% in 2017, then increased by 7bps to 0.48% in 2018, then grew by 25bps to 0.36% in 2019.
  • Business Quant data shows Return on Assets for LRMR at 0.36% in Q3 2019, 0.35% in Q2 2019, and 0.5% in Q1 2019.